Skip to main content
Modalis Therapeutics Corporation logo

Modalis Therapeutics Corporation — Investor Relations & Filings

Ticker · 4883 ISIN · JP3922600006 T Manufacturing
Open in API
Filings indexed 51 across all filing types
Latest filing 2026-03-25 Regulatory Filings
Country JP Japan
Listing T 4883

About Modalis Therapeutics Corporation

https://modalistx.com/en/

Modalis Therapeutics Corporation is a biotechnology company developing precision genetic medicines for serious disorders. The company's core technology is CRISPR-GNDM®, a proprietary epigenome editing platform. This technology regulates the expression of specific genes—selectively activating or suppressing them—without altering the underlying DNA sequence or causing double-strand breaks. CRISPR-GNDM® utilizes a compact epigenome editor designed for efficient delivery to target cells using adeno-associated virus (AAV) vectors. The company advances its programs through a hybrid model of in-house development and collaborative partnerships, with a pipeline focused on therapeutic areas such as muscular disorders, cardiomyopathy, and central nervous system (CNS) disorders.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a Japanese “確認書” (confirmation letter) submitted under the Financial Instruments and Exchange Act, certifying the correctness of the company’s annual securities report. It is not the full annual report itself (10-K/Annual Report) but a supplementary regulatory filing, and does not fit any more specific category (no board changes, dividends, capital, etc.). Therefore it falls under the fallback category “Regulatory Filings (RNS).”
2026-03-25 Japanese
有価証券報告書－第10期(2025/01/01－2025/12/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains detailed financial statements, management indicators, and business information for the fiscal year ending December 31, 2025. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) submitted under the Financial Instruments and Exchange Act. FY 2025
2026-03-25 Japanese
訂正有価証券届出書（組込方式）
Capital/Financing Update Classification · 1% confidence The document is a 'Yuka Shoken Todokesho' (Securities Registration Statement) filed with the Kanto Local Finance Bureau by Modalis Therapeutics Corporation. It details the issuance of new share acquisition rights (stock options/warrants) and corporate bonds. This type of filing is a formal regulatory document required for capital raising activities, specifically falling under the category of share issuance and capital structure changes.
2025-08-14 Japanese
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, signed by the CEO and CFO, certifying the accuracy of the company's semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (like a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 2025
2025-08-14 Japanese
半期報告書－第10期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Modalis Therapeutics Corporation with the Kanto Local Finance Bureau. It covers the interim accounting period from January 1, 2025, to June 30, 2025. It contains comprehensive financial statements, management analysis (MDA), and corporate information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-14 Japanese
有価証券届出書（組込方式）
Capital/Financing Update Classification · 1% confidence The document is a '有価証券届出書' (Securities Registration Statement) filed with the Kanto Local Finance Bureau by Modalis Therapeutics Corporation. It details the issuance of new share acquisition rights (第17回新株予約権) and convertible bonds. This type of document is a formal regulatory filing required for capital raising activities, which falls under the 'Capital/Financing Update' category in the provided schema.
2025-08-07 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.